Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review and network meta‐analysis

Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review and network meta‐analysis

<p><strong>Background</strong><br> Vascular surgery may be followed by internal bleeding due to inadequate surgical haemostasis, abnormal clotting, or surgical complications. Bleeding ranges from minor, with no transfusion requirement, to massive, requiring multiple blood pro...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Beverly, A, Ong, G, Kimber, C, Sandercock, J, Dorée, C, Welton, NJ, Wicks, P, Estcourt, LJ
Natura:	Journal article
Lingua:	English
Pubblicazione:	Cochrane Collaboration 2023

Documenti analoghi

Drugs to reduce bleeding and transfusion in adults undergoing cardiac surgery: A systematic review and network meta analysis
di: Beverly, A, et al.
Pubblicazione: (2019)

Pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a systematic review and network meta‐analysis
di: Gibbs, VN, et al.
Pubblicazione: (2024)

The difference in potential harms between whole blood and component blood transfusion in major bleeding: A rapid systematic review and meta-analysis of RCTs
di: Geneen, LJ, et al.
Pubblicazione: (2021)

Universal irradiation of platelets: does irradiation affect the quality, effectiveness, and safety of platelets for transfusion?
di: Cain, L, et al.
Pubblicazione: (2024)

Pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a Cochrane systematic review and network meta-analysis
di: Gibbs, V, et al.
Pubblicazione: (2024)

Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non‐cardiac surgery or invasive procedures
di: Huber, J, et al.
Pubblicazione: (2018)

Red cell transfusions for prevention of bleeding: a systematic review and meta-analysis of randomized controlled trials
di: Desborough, M, et al.
Pubblicazione: (2016)

A systematic review of the safety and efficacy of convalescent plasma or immunoglobulin treatment for people with severe respiratory viral infections due to coronaviruses or influenza
di: Kimber, C, et al.
Pubblicazione: (2022)

Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
di: Estcourt, L, et al.
Pubblicazione: (2012)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Russian Translation of Cochrane Plain Language Summary)
di: Crighton, GL, et al.
Pubblicazione: (2021)

Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non-cardiac surgery or invasive procedures
di: Huber, J, et al.
Pubblicazione: (2019)

Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation
di: Estcourt, L, et al.
Pubblicazione: (2014)

Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
di: Estcourt, L, et al.
Pubblicazione: (2015)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol).
di: Estcourt, L, et al.
Pubblicazione: (2014)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
di: Estcourt, L, et al.
Pubblicazione: (2014)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
di: Crighton, GL, et al.
Pubblicazione: (2015)

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
di: Estcourt, L, et al.
Pubblicazione: (2014)

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Review)
di: Estcourt, L, et al.
Pubblicazione: (2015)

Prophylactic platelet transfusions prior to surgery for people with a low platelet count
di: Estcourt, L, et al.
Pubblicazione: (2017)

Prophylactic platelet transfusions prior to surgery for people with a low platelet count
di: Estcourt, L, et al.
Pubblicazione: (2018)

Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review (Russian translation of Cochrane plain language summary)
di: Desborough, MJR, et al.
Pubblicazione: (2021)

Plasma transfusions prior to lumbar punctures and epidural catheters for people with abnormal coagulation
di: Estcourt, L, et al.
Pubblicazione: (2017)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
di: Estcourt, L, et al.
Pubblicazione: (2014)

Network meta-analysis results: pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a systematic review and network meta-analysis
di: Sandercock, J, et al.
Pubblicazione: (2023)

Interventions for preventing silent cerebral infarcts in people with sickle cell disease
di: Estcourt, LJ, et al.
Pubblicazione: (2020)

Assessing the risks of haemolysis as an adverse reaction following the transfusion of ABO incompatible plasma-containing components - a scoping review
di: McCullagh, J, et al.
Pubblicazione: (2022)

Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction
di: Estcourt, L, et al.
Pubblicazione: (2016)

Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review
di: Desborough, M, et al.
Pubblicazione: (2016)

Pharmacological interventions for the treatment of bleeding in people treated for blunt force or penetrating injury in an emergency department: a systematic review and network meta-analysis (Protocol)
di: Erasu, V, et al.
Pubblicazione: (2022)

Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia
di: Estcourt, L, et al.
Pubblicazione: (2016)

Platelet transfusion thresholds in premature neonates (PlaNeT-2 trial)
di: Estcourt, LJ
Pubblicazione: (2019)

Plasma transfusions prior to insertion of central lines for people with abnormal coagulation
di: Hall, D, et al.
Pubblicazione: (2016)

Pathogen-reduced platelets for the prevention of bleeding (protocol)
di: Butler, C, et al.
Pubblicazione: (2011)

Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia
di: Estcourt, L, et al.
Pubblicazione: (2015)

Risk of bleeding and use of platelet transfusions in patients with hematological malignancies: recurrent event analysis
di: Stanworth, S, et al.
Pubblicazione: (2015)

Prophylactic plasma transfusion for patients undergoing non-cardiac surgery
di: Huber, J, et al.
Pubblicazione: (2017)

Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia
di: Geneen, LJ, et al.
Pubblicazione: (2023)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with thrombocytopenia due to chronic bone marrow failure: a network meta-analysis and systematic review
di: Desborough, M, et al.
Pubblicazione: (2016)

Pathogen-reduced platelets for the prevention of bleeding.
di: Butler, C, et al.
Pubblicazione: (2013)

Plasma transfusions prior to lumbar punctures and epidural catheters for people with abnormal coagulation (Protocol)
di: Estcourt, L, et al.
Pubblicazione: (2017)